Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab

Lignende værker

• Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View
  af: Hu, Shi, et al.
  Udgivet: (2013)
• Comparison of the inhibition mechanisms of Adalimumab and Infliximab in treating tumor necrosis factor α-associated diseases from a molecular view.
  af: Hu, Shi, et al.
  Udgivet: (2014)
• Macrocyclic θ-defensins suppress tumor necrosis factor-α (TNF-α) shedding by inhibition of TNF-α–converting enzyme
  af: Schaal, Justin B., et al.
  Udgivet: (2018)
• Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system
  af: An, Qing, et al.
  Udgivet: (2019)
• Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
  af: Fonseca, Ashley, et al.
  Udgivet: (2021)